期刊文献+

原发性肝癌中活血化瘀类常用中药的成分及作用分析

Analysis of the components and effects of commonly used Chinese herbal medicines for activating blood and resolving stasis in primary liver cancer
下载PDF
导出
摘要 本文旨在分析活血化瘀法中对原发性肝癌常用中药的成分及作用。介绍了原发性肝癌的中药治疗历史及现状,阐述了现代药理研究方法在中药治疗中的应用。本文详细探讨了常用活血化瘀类中药及其现代药理研究,包括郁金、血竭、当归、桃仁、丹参、赤芍、红花、三棱、莪术、八月札等常用活血化瘀类药物,随后分别对这些中药的成分及其药效评价进一步地展开讨论,揭示活血化瘀法中常用中药的作用机制,包括活血散瘀、调和营血、消肿排脓、抗癌、增强机体免疫力、降低化疗副作用等方面。综上所述,本文强调了活血化瘀法中中药的重要性,这对于原发性肝癌的治疗以及预防有着重要的意义。 This article aims to analyze the components and effects of commonly used Chinese herbal medicines in the blood-activating and stasis-resolving method for primary liver cancer.The history and current status of Chinese herbal medicine treatment for primary liver cancer are introduced,and the application of modern pharmacological research methods in Chinese herbal medicine treatment is elaborated.This article discusses in detail the commonly used Chinese herbal medicines for activating blood and resolving stasis,as well as their modern pharmacological research,including Radix curcumae,Sangusis draconis,Angelica sinensis,Peach kernel,Salvia miltiorrhiza,Radix paeoniae rubra,Flos carthami,Rhizoma sparganii,Zedoary rhizome,Fructus akebiae,and other commonly used drugs for activating blood and resolving stasis.Subsequently,the components and pharmacodynamic evaluation of these Chinese herbal medicines are further discussed,revealing the mechanism of action of commonly used Chinese herbal medicines in the blood-activating and stasis-resolving method,including activating blood and resolving stasis,regulating nutrient-blood,reducing swelling and discharging pus,and in terms of anti-cancer,enhancing the body’s immune system,and reducing side effects of chemotherapy.In summary,this article emphasizes the importance of Chinese herbal medicines in blood-activating and stasis-resolving methods,which are of great significance for the treatment and prevention of primary liver cancer.
作者 王惠茹 梁爽 张骞 白彦铭 朱妍妍 石璐 杜凯凯 郝振华 李哲爽 罗志合 周彦浩 周波 WANG Huiru;LIANG Shuang;ZHANG Qian;BAI Yanming;ZHU Yanyan;SHI Lu;DU Kaikai;HAO Zhenhua;LI Zheshuang;LUO Zhihe;ZHOU Yanhao;ZHOU Bo(School of Traditional Chinese Medicine,Ningxia Medical University,Ningxia,Yinchuan 750004,China;Department of Traditional Chinese Medicine,Yinchuan Hospital of Traditional Chinese Medicine,Ningxia,Yinchuan 750001,China;Key Laboratory of Ningxia Ethnomedicine Modernization,Ministry of Education,Ningxia Medical University,Ningxia,Yinchuan 750004,China)
出处 《中国医药科学》 2024年第8期45-48,共4页 China Medicine And Pharmacy
基金 宁夏回族自治区重点研发计划项目(2021BEG03112)。
关键词 活血化瘀法 原发性肝癌 中药 成分分析 作用机制 药效评价 Blood-activating and stasis-resolving method Primary liver cancer Traditional Chinese medicine Component analysis Mechanism of action Pharmacodynamic evalua tion
  • 相关文献

参考文献15

二级参考文献306

共引文献200

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部